Trial intelligence / Profile preview

Effentora for Dyspnoea (EffenDys)

2011-005797-32Phase 2Completed

Sponsor
University of Cologne
Start
Nov 2012
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 2, randomised, open-label trial of fentanyl (2 arms), sponsored by University of Cologne. Primary endpoint: Time to onset of meaningful dyspnoea relief. Started Nov 2012; status: completed.

02

Drugs

fentanyl

Beyond the preview

Go deeper on 2011-005797-32.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-005797-32.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call